Head-To-Head Survey: DIH Holding US (DHAI) and Its Competitors

Volatility & Risk

DIH Holding US has a beta of -0.66, suggesting that its stock price is 166% less volatile than the S&P 500. Comparatively, DIH Holding US’s rivals have a beta of 1.09, suggesting that their average stock price is 9% more volatile than the S&P 500.

Profitability

This table compares DIH Holding US and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
DIH Holding US	-13.59%	-5.07%	-25.97%
DIH Holding US Competitors	-546.70%	-173.81%	-26.43%

Valuation and Earnings

This table compares DIH Holding US and its rivals revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
DIH Holding US	$64.47 million	-$8.44 million	-1.62
DIH Holding US Competitors	$986.22 million	$56.11 million	3.75

DIH Holding US’s rivals have higher revenue and earnings than DIH Holding US. DIH Holding US is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Institutional and Insider Ownership

27.8% of DIH Holding US shares are held by institutional investors. Comparatively, 47.5% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 49.6% of DIH Holding US shares are held by company insiders. Comparatively, 15.2% of shares of all “Surgical & medical instruments” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

DIH Holding US rivals beat DIH Holding US on 5 of the 9 factors compared.

DIH Holding US Company Profile

DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.